How much will a box of Regorafenib cost in 2026?

Regorafenib is an oral targeted drug mainly used to treat advanced colorectal cancer, liver cancer and gastrointestinal stromal tumors (GIST). In China, regorafenib is already on the market and is included in medical insurance, and patients can purchase it domestically. According to the latest market conditions, the price of regorafenib is approximately RMB 4,000 to RMB 5,000 per box. The specific price may vary depending on regions, hospitals and medical insurance policies. When purchasing, it is recommended that patients go to the local hospital pharmacy for consultation to learn more accurate price information and the specific situation of medical insurance reimbursement.

The original drug of regorafenib is mainly produced by the Japanese pharmaceutical company Bayer (Bayer) and is widely used in many countries and regions. In foreign markets, the price of regorafenib is usually higher, especially for the original drug. Taking Turkey as an example, the price of the original drug of regorafenib is about more than 1,000 yuan. Although it is relatively cheap, the price also fluctuates to a certain extent due to exchange rate fluctuations and local market pricing policies.

In addition to the original drug, there are also some generic versions of regorafenib from countries such as Laos, India and Bangladesh. The price of these generic drugs is significantly lower than that of the original drugs, usually ranging from a few hundred yuan to more than a thousand yuan. It is worth noting that although the prices of these generic drugs are lower, they are basically the same as the ingredients of the original drugs, and patients can make judgments based on their personal needs and doctor's recommendations when choosing.

As a targeted drug, regorafenib has relatively clear therapeutic effects and side effects, but the specific treatment cost is still a concern for many patients. In some areas, due to different medical insurance policies, patients may enjoy different levels of reimbursement, reducing the financial burden. Therefore, it is recommended that patients conduct detailed consultation with the hospital pharmacy before treatment to understand the applicable medical insurance reimbursement ratio and drug purchase channels.

Keyword tags: Regorafenib,Regorafenib, drug price, medical insurance reimbursement, original drug, generic drug, colorectal cancer, liver cancer, gastrointestinal stromal tumor, targeted therapy

Reference materials:https://www.stivarga-us.com/